Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
NCT05677880
This study is recruiting at 10 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
This is an observational study to better understand the risk factors and progression of CADASIL, a leading cause of vascular cognitive impairment and dementia (VCID). 575 participants will be enrolled and can expect to be on study for up to 5 years.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- CADASIL
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Wisconsin, Madison
- Last updated on ClinicalTrials.gov
- January 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of California · Los Angeles, CA
- University of California · San Francisco, CA
Colorado · 1
- University of Colorado · Denver, CO
Georgia · 1
- Georgia State University Research Foundation · Atlanta, GA
Illinois · 1
- Loyola University · Chicago, IL
New York · 1
- Columbia University · New York, NY
Oregon · 1
- Oregon Health & Science University · Portland, OR
Rhode Island · 1
- Brown University · Providence, RI
Utah · 1
- University of Utah · Salt Lake City, UT
Washington · 1
- University of Washington · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.